CTI Life Sciences Fund
Quebecctisciences.com
Overview
CTI Life Sciences Fund is a knowledge-driven boutique venture capital firm that aims to deliver strong results on investments in Life Sciences . Their mission is to catalyze emerging science, transform business objectives, and invest in scalable companies within Canada, the United States and Europe . They focus on pre-clinical and early clinical-stage therapeutics companies, with a secondary focus on mid-and growth-stage medtech opportunities and an exploratory focus on Healthcare Services and Healthcare IT .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Domain Therapeutics | Feb 2026 | Series B | Co-investor |
| Kainova Therapeutics | Feb 2026 | Series B | Co-investor |
| Aeovian Pharmaceuticals | Dec 2025 | Series B | Lead |
| Thryv Therapeutics | Sep 2025 | Series B | Co-investor |
| Glycomine | Apr 2025 | Series C | Lead |
Key People
Laurence Rulleau
Managing Partner At CTI LSF III
Youssef Bennani
Managing Partner-CTI Life Sciences
Xin Hang
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
